News search

E.g., 30/10/2026
E.g., 30/10/2026
celulas_pluripotentes
About the CNIC
25 Sep 2026

The new equipment will facilitate work with mouse embryonic stem cells and human induced pluripotent stem cells (hiPSCs), fundamental tools for developing experimental models of cardiovascular disease

celulas_pluripotentes
About the CNIC
25 Sep 2026

The new equipment will facilitate work with mouse embryonic stem cells and human induced pluripotent stem cells (hiPSCs), fundamental tools for developing experimental models of cardiovascular disease

The R33Q mutation in calsequestrin 2 (CASQ2) disrupts calcium control in heart cells and activates protein-degradation mechanisms.
Research
23 Sep 2026

Researchers at the CNIC, in collaboration with the University of Pavia and IRCCS Istituti Clinici Scientifici Maugeri, have found that activation of the enzyme calpain contributes to the development of a severe inherited arrhythmia.

Yolanda Martí-Mateos, José Antonio Enríquez y Rebeca Acín-Pérez.
Research
6 Aug 2026

The protein, OMA1, delays immune-system overactivation, liver fibrosis, and liver cancer during aging

Rocío Sierra, Miguel Torres, Cristina Villa del Campo, Enrique Calvo, Jesús Vázquez y Consuelo Marín-Vicente.
Research
24 Jun 2026

Two CNIC teams have developed a pioneering technique to analyze proteins in individual cardiomyocytes and uncover new clues about cardiac regeneration

Florian Weinberg
About the CNIC
23 Jun 2026

CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease

Left: Hesham Sadek MD, PhD. Right: Ivan Menendez-Montes, PhD
Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
Research
22 May 2026

A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors